tirzepatide latest news Eli Lilly sues companies selling alternative versions of its weight loss drug FDA approves new obesity drug

Acute Pancreatitis Acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with GLP-1 receptor agonists, including semaglutide [see ADVERSE REACTIONS ]

Record-breaking Retatrutide 26.6% weight loss (placebo-adjusted, efficacy estimand) in its first phase 3 trial and an improvement to knee osteoarthritis breakingground.substack.com/p/5-breakthrou 5 medical breakthroughs this week () 1

Does marine collagen really work for glowing skin

By activating GLP-1 receptors, Wegovy: Delays gastric emptying : Food remains in the stomach longer, promoting satiety but potentially causing nausea, bloating, and early fullness

This is not one of those situations where you can take both medications and check in with your doctor once a year

Europe & Middle East: Portugal and Dubai